Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Mar 15, 2019; 11(3): 227-237
Published online Mar 15, 2019. doi: 10.4251/wjgo.v11.i3.227
Table 3 Univariate and multivariate analysis of prognostic factors for disease-free survival
VariableUnivariate analysis
Multivariate analysis
HRP valueHRP value
Group (RF ablation)0.272 (0.174, 0.427)< 0.0010.352 (0.205, 0.605)< 0.001
Age1.036 (1.012, 1.060)0.0031.015 (0.987, 1.043)0.306
Sex (female)1.096 (0.650, 1.847)0.732
Etiology (hepatitis B virus) 10.726
Hepatitis C virus1.507 (0.789, 2.878)0.31
NBNC1.121 (0.483, 2.601)1
Liver cirrhosis (absence)1.526 (0.916, 2.544)0.105
Tumor size0.976 (0.658, 1.448)0.904
α-fetoprotein1.000 (0.999, 1.000)0.391
Platelet count0.991 (0.987, 0.995)< 0.0010.998 (0.993, 1.004)0.542
Alanine aminotransferase1.008 (1.000, 1.017)0.0451.011 (1.003, 1.020)0.006
Total bilirubin0.995 (0.540, 1.833)0.988
Albumin0.281 (0.168, 0.470)< 0.0010.481 (0.269, 0.860)0.014
Prothrombin time (INR)147.887 (13.992, 1563.115)< 0.0014.212 (0.195, 90.886)0.359